FDA grants Bayer's HYRNUO accelerated approval as first-line NSCLC therapy Sep 9, 2026 10:22PM
Bayer and Iambic partner on AI-driven small molecule drug discovery Jun 22, 2026 08:01AM
Bayer names Kacy Perry head of Crop Science Canada Jun 18, 2026 03:22PM
Bayer reports phase I results for prostate cancer therapy Feb 27, 2026 12:48PM
Bayer's XOFIGO plus enzalutamide reduces death risk by 24% in prostate cancer Feb 26, 2026 11:28AM


Feb 5, 2026 12:15PM Bayer's asundexian reduces stroke risk by 26% in phase III trial